NO20081835L - Behandlingsmetoder ved bruk av oksytocin receptoragonister - Google Patents
Behandlingsmetoder ved bruk av oksytocin receptoragonisterInfo
- Publication number
- NO20081835L NO20081835L NO20081835A NO20081835A NO20081835L NO 20081835 L NO20081835 L NO 20081835L NO 20081835 A NO20081835 A NO 20081835A NO 20081835 A NO20081835 A NO 20081835A NO 20081835 L NO20081835 L NO 20081835L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- receptor agonists
- treatment
- oxytocin receptor
- schizophrenia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Metoder for behandling og forhindring av angst, angstrelaterte lidelser, schizofreni og schizofrenirelaterte lidelser er beskrevet her hvor nevnte metoder omfatter administrering av oksytocinreseptoragonister.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72965605P | 2005-10-24 | 2005-10-24 | |
PCT/US2006/040425 WO2007050353A2 (en) | 2005-10-24 | 2006-10-17 | Tricyclic compounds useful as oxytocin receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081835L true NO20081835L (no) | 2008-05-20 |
Family
ID=37834124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081835A NO20081835L (no) | 2005-10-24 | 2008-04-16 | Behandlingsmetoder ved bruk av oksytocin receptoragonister |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070117794A1 (no) |
EP (1) | EP1948662A2 (no) |
JP (1) | JP2009512730A (no) |
KR (1) | KR20080063848A (no) |
CN (1) | CN101296929A (no) |
AU (1) | AU2006306547A1 (no) |
BR (1) | BRPI0617770A2 (no) |
CA (1) | CA2626180A1 (no) |
CR (1) | CR9923A (no) |
EC (1) | ECSP088398A (no) |
GT (1) | GT200800052A (no) |
IL (1) | IL190900A0 (no) |
NO (1) | NO20081835L (no) |
RU (1) | RU2008114374A (no) |
WO (1) | WO2007050353A2 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2954167A1 (fr) | 2009-09-04 | 2011-06-24 | Centre Nat Rech Scient | Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique |
US9101569B2 (en) | 2010-05-18 | 2015-08-11 | Universite De Geneve | Methods for the treatment of insulin resistance |
WO2011146806A1 (en) * | 2010-05-21 | 2011-11-24 | University Of Florida Research Foundation, Inc. | Methods for reducing anesthetic-inducible epileptogenic and neurotoxic effects |
WO2012016229A2 (en) | 2010-07-30 | 2012-02-02 | The Regents Of The University Of California | Oxytocin treatment to improve memory and modify blood glucose |
WO2016025629A1 (en) | 2014-08-12 | 2016-02-18 | The Regents Of The University Of California | Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues |
RU2715384C2 (ru) | 2015-07-06 | 2020-02-27 | Де Юниверсити Оф Сидней | Терапевтические соединения и композиции для лечения социальных расстройств и расстройств, связанных с употреблением психоактивных веществ |
RU2019120162A (ru) * | 2016-12-12 | 2021-01-12 | Де Юниверсити Оф Сидней | Непептидные агонисты рецепторов окситоцина |
EP3768320A1 (en) | 2018-03-23 | 2021-01-27 | Cytoo | Alk5 inhibitors as skeletal muscle hypertrophy inducers |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6900200B2 (en) * | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
GB0115515D0 (en) * | 2001-06-25 | 2001-08-15 | Ferring Bv | Oxytocin agonisys |
GB0120051D0 (en) * | 2001-08-16 | 2001-10-10 | Ferring Bv | Oxytocin agonists |
EP1449844A1 (en) * | 2003-02-14 | 2004-08-25 | Ferring B.V. | benzamide derivatives as oxytocin agonists and vasopressin antagonists |
EP1512687A1 (en) * | 2003-09-05 | 2005-03-09 | Ferring B.V. | Piperazines as oxytocin agonists |
-
2006
- 2006-10-17 JP JP2008537762A patent/JP2009512730A/ja not_active Withdrawn
- 2006-10-17 EP EP06826053A patent/EP1948662A2/en not_active Withdrawn
- 2006-10-17 WO PCT/US2006/040425 patent/WO2007050353A2/en active Application Filing
- 2006-10-17 RU RU2008114374/14A patent/RU2008114374A/ru unknown
- 2006-10-17 BR BRPI0617770-0A patent/BRPI0617770A2/pt not_active Application Discontinuation
- 2006-10-17 CA CA002626180A patent/CA2626180A1/en not_active Abandoned
- 2006-10-17 CN CNA200680039564XA patent/CN101296929A/zh active Pending
- 2006-10-17 KR KR1020087012049A patent/KR20080063848A/ko not_active Application Discontinuation
- 2006-10-17 AU AU2006306547A patent/AU2006306547A1/en not_active Abandoned
- 2006-10-23 US US11/584,995 patent/US20070117794A1/en not_active Abandoned
-
2008
- 2008-04-15 IL IL190900A patent/IL190900A0/en unknown
- 2008-04-16 NO NO20081835A patent/NO20081835L/no not_active Application Discontinuation
- 2008-04-24 EC EC2008008398A patent/ECSP088398A/es unknown
- 2008-04-24 GT GT200800052A patent/GT200800052A/es unknown
- 2008-04-24 CR CR9923A patent/CR9923A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007050353A3 (en) | 2007-06-21 |
BRPI0617770A2 (pt) | 2011-08-09 |
CR9923A (es) | 2008-06-27 |
CN101296929A (zh) | 2008-10-29 |
RU2008114374A (ru) | 2009-12-10 |
ECSP088398A (es) | 2008-06-30 |
EP1948662A2 (en) | 2008-07-30 |
IL190900A0 (en) | 2008-11-03 |
CA2626180A1 (en) | 2007-05-03 |
US20070117794A1 (en) | 2007-05-24 |
WO2007050353A2 (en) | 2007-05-03 |
KR20080063848A (ko) | 2008-07-07 |
GT200800052A (es) | 2008-10-06 |
AU2006306547A1 (en) | 2007-05-03 |
JP2009512730A (ja) | 2009-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081835L (no) | Behandlingsmetoder ved bruk av oksytocin receptoragonister | |
UA109878C2 (uk) | Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти) | |
CY1121135T1 (el) | Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος | |
EA201000016A1 (ru) | Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями | |
DE602006008456D1 (de) | Amylin und amylinagonisten für die behandlung von psychiatrischen erkrankungen und störungen | |
CY1117317T1 (el) | Αναστολεις κινασης janus για θεραπεια ξηροφθαλμιας και αλλων σχετικων με τον οφθαλμο ασθενειων | |
EA200700262A1 (ru) | Арилидены для лечения заболеваний, опосредуемых эстроген-родственным рецепторам альфа | |
ATE528002T1 (de) | Pyridoncarboxamidderivate zur behandlung hyperproliferativer und angiogenese-vermittelter leiden | |
BRPI0506970B8 (pt) | derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior | |
EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
EA200971077A1 (ru) | Гетероциклические модуляторы киназы | |
ATE478072T1 (de) | Spiroimidazol-derivate als ppar-modulatoren | |
NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
ATE497961T1 (de) | Als proteinkinaseinhibitoren geeignete verbindungen | |
SG179410A1 (en) | Therapeutic uses of inhibitors of rtp801 | |
ATE484501T1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
EA201070609A1 (ru) | Способы лечения ожирения и ассоциированных с ожирением заболеваний и расстройств | |
NO20092634L (no) | Fremgangsmate for fremstilling av piperazinyl og diazepanyl benzamidderivater | |
UY29995A1 (es) | Uso de un antagonista de cb1 para tratar efectos secundarios y síntomas negativos de la esquizofrenia | |
EA200802072A1 (ru) | Ликопин для лечения нарушения обмена веществ | |
NI200700032A (es) | Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas | |
CY1109666T1 (el) | Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας | |
ECSP10010379A (es) | Derivados de oxindol sustituido y su uso para el tratamiento de enfermedades dependientes de la vasopresina | |
CY1116166T1 (el) | Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori | |
EA200801240A1 (ru) | Новые способы получения производных циклопропиламида |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |